Search Results 421-430 of 16991 for Semaglutide
Part A (dose regimen finding) will allow definition of the maximum tolerated dose (MTD) through dose escalation and possible dose interval modification. In Part ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
About this study. The investigators will evaluate a technology-enabled strategy designed to promote medication adherence, routinely monitor regimen use, ...
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered ...
The purpose of this study is to compare IgG4-related disease remission and relapse rates between patients who had induction rituximab treatment with or without ...
About this study. The purpose of this study is to use magnetic resonance elastography to assess heart muscle stiffness in patients with cardiac amloidosis ...
Dolutegravir and lamivudine combination is used to treat human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency ...
The purpose of this study is to assess the possibility, safety, and therapeutic effect of administering a short, quick course of high-dose radiation treatment ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.